Tien Liang BioTech Co., Ltd.
4127.TWO
Price:
$30.45
Market Cap:
$1.39B
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete's foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels. In addition, the company offers healthcare p...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
4127.TWO
PE Ratio
[-435.00]
ROE
[-4.91%]
Current Ratio
[0.51]
Dividend Yield
[0%]
Enterprise Value
[1.76B]
Dividend History
The ROE as of December 2025 (TTM) for Tien Liang BioTech Co., Ltd. (4127.TWO) is -4.91%
According to Tien Liang BioTech Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -4.91%. This represents a change of 247.27% compared to the average of -1.41% of the last 4 quarters.
Tien Liang BioTech Co., Ltd. (4127.TWO) Historical ROE (quarterly & annually)
How has 4127.TWO ROE performed in the past?
The mean historical ROE of Tien Liang BioTech Co., Ltd. over the last ten years is 2.63%. The current -4.91% ROE has changed -286.88% with respect to the historical average. Over the past ten years (40 quarters), 4127.TWO's ROE was at its highest in in the March 2025 quarter at 3.54%. The ROE was at its lowest in in the June 2025 quarter at -10.79%.
Average
2.63%
Median
3.02%
Minimum
-14.06%
Maximum
12.52%
Tien Liang BioTech Co., Ltd. (4127.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Tien Liang BioTech Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.22%
Maximum Annual ROE = 12.52%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -14.06%
| Year | ROE | Change |
|---|---|---|
| 2024 | 2.45% | -31.96% |
| 2023 | 3.60% | -71.27% |
| 2022 | 12.52% | 11.22% |
| 2021 | 11.26% | -180.05% |
| 2020 | -14.06% | -Infinity% |
Tien Liang BioTech Co., Ltd. (4127.TWO) Average ROE
How has 4127.TWO ROE performed in the past?
The current ROE of Tien Liang BioTech Co., Ltd. (4127.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.19%
5-year avg
3.15%
10-year avg
2.63%
Tien Liang BioTech Co., Ltd. (4127.TWO) ROE vs. Peers
How is 4127.TWO’s ROE compared to its peers?
Tien Liang BioTech Co., Ltd.’s ROE is greater than Anxo Pharmaceutical Co., Ltd. (-4.18%), greater than Excelsior Biopharma Inc. (-13.77%), greater than Prince Pharmaceutical Co., Ltd. (-1.50%), greater than Allied Biotech Corporation (-4.90%), greater than Enimmune corporation (-70.32%), less than DV Biomed Co., Ltd. (0.24%), greater than NaviFUS Corp. (-20.73%), less than Bioptik Technology Incorporation (7.27%), less than Genetics Generation Advancement Corp. (5.91%), less than Lagis Enterprise Co., Ltd. (11.14%),
| Company | ROE | Market cap |
|---|---|---|
| -4.18% | $1.21B | |
| -13.77% | $1.36B | |
| -1.50% | $1.12B | |
| -4.90% | $2.36B | |
| -70.32% | $1.44B | |
| 0.24% | $1.15B | |
| -20.73% | $1.47B | |
| 7.27% | $1.52B | |
| 5.91% | $1.33B | |
| 11.14% | $1.35B |
Build a custom stock screener for Tien Liang BioTech Co., Ltd. (4127.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tien Liang BioTech Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Tien Liang BioTech Co., Ltd. (4127.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Tien Liang BioTech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Tien Liang BioTech Co., Ltd.'s ROE?
How is the ROE calculated for Tien Liang BioTech Co., Ltd. (4127.TWO)?
What is the highest ROE for Tien Liang BioTech Co., Ltd. (4127.TWO)?
What is the 3-year average ROE for Tien Liang BioTech Co., Ltd. (4127.TWO)?
What is the 5-year average ROE for Tien Liang BioTech Co., Ltd. (4127.TWO)?
How does the current ROE for Tien Liang BioTech Co., Ltd. (4127.TWO) compare to its historical average?